BLADDER CANCER

Browse all BLADDER CANCER
Bladder, Kidney, and Prostate Cancer Highlights From ASCO GU 2026

BLADDER CANCER

Bladder, Kidney, and Prostate Cancer Highlights From ASCO GU 2026

Petros Grivas, MD, PhD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

ASCO GU 2026: Key Updates in Bladder, Prostate, and Kidney Cancer

BLADDER CANCER

ASCO GU 2026: Key Updates in Bladder, Prostate, and Kidney Cancer

Charbel Matar, MD

Novel HER2–Targeting Therapies in Urothelial Cancer

BLADDER CANCER

Novel HER2–Targeting Therapies in Urothelial Cancer

Miles Hsu, MD, Brendan Guercio, MD

Circulating Tumor DNA to Guide Treatment in Muscle-Invasive Bladder Cancer

BLADDER CANCER

Circulating Tumor DNA to Guide Treatment in Muscle-Invasive Bladder Cancer

Brendan Guercio, MD, Andrea Apolo, MD

PROSTATE CANCER

Browse all PROSTATE CANCER
Community Takeaways From ASCO GU 2026

PROSTATE CANCER

Community Takeaways From ASCO GU 2026

Regina Barragan-Carrillo, MD, Raji Shameem, MD

ASCO GU 2026: Experts Highlight Key Updates in Prostate Cancer

PROSTATE CANCER

ASCO GU 2026: Experts Highlight Key Updates in Prostate Cancer

Brooke Kania, DO, Sindhuja Kadambi, MD, MS

A Personalized Approach to Treating GU Cancers

PROSTATE CANCER

A Personalized Approach to Treating GU Cancers

Sophia Kamran, MD, Natalie Reizine, MD

PEACE-3 OS Data Support Radium-223 Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

PROSTATE CANCER

PEACE-3 OS Data Support Radium-223 Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Sindhuja Kadambi, MD, MS, Karine Tawagi, MD

RCC

Browse all RCC
Positive Trials for Belzutifan in Earlier Treatment Lines for RCC

RCC

Positive Trials for Belzutifan in Earlier Treatment Lines for RCC

Michael Serzan, MD, Toni Choueiri, MD

Radiotherapy Strategies in Metastatic Clear Cell Renal Cell Carcinoma

RCC

Radiotherapy Strategies in Metastatic Clear Cell Renal Cell Carcinoma

Michael Serzan, MD, Shreyas Kalantri, MD

Cabozantinib and Novel Doublets in Advanced RCC

RCC

Cabozantinib and Novel Doublets in Advanced RCC

Nicholas Simon, MD, Sumanta Pal, MD, FASCO

First-Line Treatment Strategies in Metastatic Renal Cell Carcinoma

RCC

First-Line Treatment Strategies in Metastatic Renal Cell Carcinoma

Andre Kydd, MD, PhD, Nicholas Simon, MD